Efficacy and Safety of Ibrutinib Combined with Standard First-Line Treatment or As Substitute for Autologous Stem Cell Transplantation in Younger Patients with Mantle Cell Lymphoma: Results from the Randomized Triangle Trial By the European MCL Network

Authors :: Martin Dreyling
Jeanette K. Doorduijn
Eva Gine
Mats Jerkeman
Jan Walewski
Martin Hutchings
Ulrich Mey
Jon Riise
Marek Trneny
Vibeke K.J. Vergote
Melania Celli
Ofer Shpilberg
Maria Gomes da Silva
Sirpa Leppa
Linmiao Jiang
Christiane Pott
Wolfram Klapper
Döndü Gözel
Christian Schmidt
Michael Unterhalt
Marco Ladetto
Eva Hoster
Source :: Blood. 140:1-3
Publication Year :: 2022
Publisher :: American Society of Hematology, 2022.

Full Text Access

Tools